Clin2
NCT07043686Possibly a fitRecruiting

Cerebrolysin for early stroke recovery

Ischemic Stroke, AcuteRehabilitation OutcomeCerebrolysin

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests if adding Cerebrolysin to standard rehabilitation helps people recover arm and hand function better after a first-time, moderate stroke. You may be eligible if you had a stroke and can follow simple instructions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You had your first stroke (no prior stroke or disability)
  • Your stroke was caused by a blood clot (ischemic stroke)
  • Your stroke symptoms are moderate (NIHSS score between 6 and 12)
  • You are able to perform the arm and hand function test (ARAT test)
  • You are willing and able to give signed consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06339411Not yet recruiting· Phase 2
Cerebrolysin after late clot removal for stroke

This trial tests whether Cerebrolysin (a medication given through an IV) can help improve recovery after a stroke when given after a successful clot-removal procedure that happened several hours after the stroke began. It is being tested in people who had a large-vessel stroke in the front of the brain and meets certain imaging criteria. The goal is to see if the drug can reduce disability and improve recovery.

NCT06897176Recruiting· Phase 4
Cerebrolysin for speech recovery after stroke

This study tests whether a medicine called Cerebrolysin can help improve speech in people who have trouble speaking after a stroke. It is for Korean speakers who had their first stroke within the last month.

Seoul
NCT04427241Recruiting· Phase 4
Testing Cerebrolysin for prolonged brain injury after bleeding stroke

This study tests whether Cerebrolysin can improve recovery in people who remain in a vegetative or minimally conscious state more than 4 weeks after a bleeding stroke. It also tracks safety, to make sure the treatment is not causing harmful side effects.

Seoul
NCT06899464Not yet recruiting· Phase 4
Testing cerebrolysin for bleeding stroke within 6 hours

This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.

NCT06995625Recruiting· Phase 1
Stem cell particles for recent stroke recovery

This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.

Suwon, Gyeonggi-do
NCT07846488Not yet recruiting
Acupuncture plus rehabilitation for stroke recovery

This trial tests whether combining acupuncture with standard rehabilitation helps people recover better after an ischemic (blockage-type) stroke. It focuses on improving movement on one side and improving swallowing problems.

Hanoi, Hanoi

Hear when a new Rehabilitation Outcome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.